Prostate Cancer

ASCO has endorsed new prostate cancer survivorship care guidelines from the American Cancer Society that provide a structure to help prostate cancer patients with localized disease to receive high quality care from specialists and primary care physicians.

Recent results from the phase 2 TERRAIN trial showed Xtandi increased progression-free survival by nearly 10 months compared with Casodex in patients with metastatic castration-resistant prostate cancer.

Raoul Concepcion, a urologist with Urology Associates in Nashville, Tenn., explains Gleason score and Gleason grade as it relates to a prostate cancer diagnosis.

Men undergoing prostate cancer treatment should give special attention to ensuring good pelvic floor strength in order to reduce side effects of treatment and maximize urinary and sexual function.

One-third of men over 70 years of age who undergo radical prostatectomy for prostate cancer and then experience biochemical recurrence have no need for salvage treatment, according to a recent study.

Prostate cancer drug Xtandi, as well as the blood cancer drug Imbruvica, may help additional patients with these cancers.

What began as an awareness campaign—men sporting mustaches in November in support of men's health—now has spurred one of the largest investments in improving the quality of life for men with prostate cancer.

Several studies announcing the latest research in different cancers, including prostate, breast and lung cancers, were presented at the 2014 European Society of Medical Oncology's annual meeting in Madrid, Spain.

Whether to opt for surgery or radiation to treat localized prostate cancer depends mainly on the stage and grade of disease, but both therapies are acceptable forms of treatment.

Maintaining bone health is essential throughout cancer treatment.

Updates from ASCO's Genitourinary Cancers Symposium.

Reel Recovery offers free fly-fishing retreats for men recovering from cancer.

Patients should research both the surgeon and the technique when deciding on treatment.

Dietary supplement Pomi-T lowers biomarker levels associated with prostate cancer.

The latest in cancer prevention, diagnosis & treatment.

The latest in cancer prevention, diagnosis & treatment.

Urinary incontinence after a cancer diagnosis can be managed.

New Routine: Caring for those with metastatic disease calls for flexibility, commitment.

Put prostate cancer screening into perspective.

Proton therapy works against some tumors, but whether it's best for prostate cancer is still unknown.

Treatment options for prostate cancer.

Vaccines help the immune system uncover malignant cells.

Men with metastatic prostate cancer lived longer with continuous hormone therapy compared with intermittent therapy.

Updates from the American Society of Clinical Oncology meetings on genitourinary and gastrointestinal cancers.

Research was presented at the ASCO Genitourinary Cancers Symposium, including advancements in prostate cancer.

Q: My doctor suggests I get a PSA test, but I want to avoid unnecessary treatment. What do you suggest?

An introduction to prostate cancer

Reducing your risk of prostate cancer.

A guide to potential side effects of prostate cancer treatment.

How to deal with sexual dysfunction after prostate cancer.